ATE269085T1 - Verwendung von diltiazem zur behandlung von pathologien der netzhaut - Google Patents
Verwendung von diltiazem zur behandlung von pathologien der netzhautInfo
- Publication number
- ATE269085T1 ATE269085T1 AT99946279T AT99946279T ATE269085T1 AT E269085 T1 ATE269085 T1 AT E269085T1 AT 99946279 T AT99946279 T AT 99946279T AT 99946279 T AT99946279 T AT 99946279T AT E269085 T1 ATE269085 T1 AT E269085T1
- Authority
- AT
- Austria
- Prior art keywords
- diltiazem
- pathologies
- treat retina
- treat
- retina pathologies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Prostheses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9812364A FR2784030B1 (fr) | 1998-10-02 | 1998-10-02 | Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine |
| PCT/FR1999/002346 WO2000020006A1 (fr) | 1998-10-02 | 1999-10-01 | Utilisation du diltiazem pour le traitement de pathologies de la retine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE269085T1 true ATE269085T1 (de) | 2004-07-15 |
Family
ID=9531128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99946279T ATE269085T1 (de) | 1998-10-02 | 1999-10-01 | Verwendung von diltiazem zur behandlung von pathologien der netzhaut |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6716835B1 (de) |
| EP (1) | EP1117408B9 (de) |
| JP (1) | JP2002526411A (de) |
| AT (1) | ATE269085T1 (de) |
| AU (1) | AU5870099A (de) |
| DE (1) | DE69918145T2 (de) |
| ES (1) | ES2219060T3 (de) |
| FR (1) | FR2784030B1 (de) |
| WO (1) | WO2000020006A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823221B1 (fr) | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
| US7445777B2 (en) | 2002-10-01 | 2008-11-04 | Paola Ammannati | Enzymatic treatment of retinitis pigmentosis |
| KR102187034B1 (ko) | 2009-01-16 | 2020-12-04 | 엑셀리시스, 인코포레이티드 | 암 치료용 ｎ-（４-｛〔６，７-비스（메틸옥시）퀴놀린-4-일〕옥시｝페닐）-ｎ＇-（４-플루오로페닐）사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형 |
| US20110021974A1 (en) * | 2010-10-05 | 2011-01-27 | Shantha Totada R | Retinitis pigmentosa treatment and prophalaxis |
| EP2731987B1 (de) | 2011-07-15 | 2017-10-04 | Solvay Specialty Polymers Italy S.p.A. | Fluorpolymerzusammensetzung für mehrschichtige laminate |
| EP3412684B1 (de) | 2013-07-31 | 2022-04-06 | Novartis AG | Neuartige auswahlvektoren sowie verfahren zur auswahl eukaryotischer wirtszellen |
| JP6954582B2 (ja) * | 2016-12-22 | 2021-10-27 | 国立大学法人滋賀医科大学 | 医薬組成物 |
| FR3081325B1 (fr) | 2018-05-23 | 2020-10-09 | Univ Claude Bernard Lyon | Diltiazem pour son utilisation dans le traitement des infections microbiennes |
| WO2020123312A1 (en) * | 2018-12-09 | 2020-06-18 | Weinberg Assa | Method to prevent and treat macular degeneration by vasodilators |
| FR3106055B1 (fr) | 2020-01-13 | 2022-01-28 | Centre Nat Rech Scient | Combinaison de diltiazem et autres agents antiviraux |
| FR3108033B1 (fr) | 2020-03-10 | 2023-04-21 | Univ Claude Bernard Lyon | COMPOSES ANTIVIRAUX ET LEURS COMBINAISONS POUR TRAITER L’INFECTION VIRALE PAR LE SARS-CoV-2 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990006118A1 (en) * | 1988-12-05 | 1990-06-14 | Houston Biotechnology Incorporated | Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction |
| US5597809A (en) * | 1994-06-23 | 1997-01-28 | Massachusetts Eye & Ear Infirmary | Treatment of optic neuritis |
| US5431907A (en) * | 1994-08-03 | 1995-07-11 | Abelson; Mark B. | Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents |
| DE19718826A1 (de) * | 1997-05-05 | 1998-11-12 | Marion S Dr Eckmiller | Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung |
-
1998
- 1998-10-02 FR FR9812364A patent/FR2784030B1/fr not_active Expired - Fee Related
-
1999
- 1999-10-01 DE DE69918145T patent/DE69918145T2/de not_active Expired - Fee Related
- 1999-10-01 JP JP2000573365A patent/JP2002526411A/ja active Pending
- 1999-10-01 WO PCT/FR1999/002346 patent/WO2000020006A1/fr active IP Right Grant
- 1999-10-01 AT AT99946279T patent/ATE269085T1/de not_active IP Right Cessation
- 1999-10-01 US US09/806,577 patent/US6716835B1/en not_active Expired - Fee Related
- 1999-10-01 AU AU58700/99A patent/AU5870099A/en not_active Abandoned
- 1999-10-01 ES ES99946279T patent/ES2219060T3/es not_active Expired - Lifetime
- 1999-10-01 EP EP99946279A patent/EP1117408B9/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69918145T2 (de) | 2005-08-11 |
| FR2784030B1 (fr) | 2002-12-20 |
| AU5870099A (en) | 2000-04-26 |
| DE69918145D1 (de) | 2004-07-22 |
| EP1117408B9 (de) | 2004-11-10 |
| EP1117408A1 (de) | 2001-07-25 |
| WO2000020006A1 (fr) | 2000-04-13 |
| JP2002526411A (ja) | 2002-08-20 |
| EP1117408B1 (de) | 2004-06-16 |
| FR2784030A1 (fr) | 2000-04-07 |
| US6716835B1 (en) | 2004-04-06 |
| ES2219060T3 (es) | 2004-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| DE60118544D1 (de) | Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren | |
| EP1021179A4 (de) | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems | |
| DK0817648T3 (da) | Antagonister mod vaskulære endotelcellevækstfaktorer | |
| ATE446097T1 (de) | Verwendung von uridin in kombination mit cholin zur behandlung von gedächtnisstörungen | |
| CY1111912T1 (el) | Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων | |
| DE69936335D1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| ATE389411T1 (de) | Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz | |
| DE60108857D1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
| DE69839815D1 (de) | Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten | |
| HK1051499A1 (en) | Method for treating ocular pain | |
| ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
| ATE269085T1 (de) | Verwendung von diltiazem zur behandlung von pathologien der netzhaut | |
| DE60304695D1 (de) | 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN | |
| DE69638281D1 (de) | Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen | |
| ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| DE60033576D1 (de) | Methoden zum screening knochenmorphogenetishemimetika | |
| ATE326534T1 (de) | Methode zur behandlung von muskelkrankheiten | |
| ATE298246T1 (de) | Aktiviertes protein c zur behandlung von pankreatitis | |
| DE69924284D1 (de) | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten | |
| NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
| ATE369143T1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
| DE69926996D1 (de) | Verwendung von riluzol zur behandlung der retinalischemie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |